Adlai Nortye Ltd. American Depositary Shares (ANL)

Adlai Nortye Ltd. American Depositary Shares (ANL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $999M; returns 1 day +0.0%, 1 week -4.1%, 1 year +537.3%.

Adlai Nortye Ltd. (ANL) is a global clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies for a spectrum of tumor types, with dual R&D centers in the U.S. and China.

Groups ANL belongs to

• Healthcare
• Biotechnology
• Clinical Stage Biotech
• Oncology
• Cancer Therapeutics
• Clinical Stage
• Biopharmaceutical
• Life Sciences
• R&D
• Antibody-Drug Conjugates

ANL financial model: income statement, cash flow and balance sheet